Have a personal or library account? Click to login
Management Heart Failure with Preserved Ejection Fraction: A Mini Review Cover

Management Heart Failure with Preserved Ejection Fraction: A Mini Review

South East European Journal of Cardiology
Volume 4 (2023): Issue 1 (December 2023)
By: Sidhi Laksono and  Robby Franata  
Open Access
|Dec 2023

References

  1. Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591-602. https://doi.org/10.1038/nrcardio.2017.65 PMid:28492288
    Search in Google ScholarBack to article
  2. Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021;23(3):352-80. https://doi.org/10.1016/j.cardfail.2021.01.022 PMid:33605000
    Search in Google ScholarBack to article
  3. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. https://doi.org/10.1093/eurheartj/ehab368 PMid:34447992
    Search in Google ScholarBack to article
  4. Van Aelst LN, Arrigo M, Placido R, Akiyama E, Girerd N, Zannad F, et al. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion. Eur J Heart Fail. 2018;20(4):738-47. https://doi.org/10.1002/ejhf.1050 PMid:29251818
    Search in Google ScholarBack to article
  5. Omote K, Verbrugge FH, Sorimachi H, Omar M, Popovic D, Obokata M, et al. Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea. Eur J Heart Fail. 2022;387(12):1089-98. https://doi.org/10.1002/ejhf.2747 PMid:36420788
    Search in Google ScholarBack to article
  6. Kumar AA, Gupta DK. Heart failure with preserved ejection fraction. In: Hayes KM, Dellise NR, editors. Managing Heart Failure in Primary Care: A Case Study Approach. Cham: Springer; 2023. https://doi.org/10.1007/978-3-031-20193-6_7
    Search in Google ScholarBack to article
  7. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145:895-1032. https://doi.org/10.1161/CIR.0000000000001063
    Search in Google ScholarBack to article
  8. Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol. 2023;81(18):1810-34. https://doi.org/10.1016/j.jacc.2023.01.049 PMid:37137592
    Search in Google ScholarBack to article
  9. Desai AS, Lam CS, McMurray JJ, Redfield MM. How to manage heart failure with preserved ejection fraction: Practical guidance for clinicians. JACC Heart Fail. 2023;11(6):619-36. https://doi.org/10.1016/j.jchf.2023.03.011 PMid:37140514
    Search in Google ScholarBack to article
  10. Hibodeau JT, Turer AT, Gualano SK, Ayers CR, Velez-Martinez M, Mishkin JD, et al. Characterization of a novel symptom of advanced heart failure: Bendopnea. JACC Heart Fail. 2014;2(1):24-31. https://doi.org/10.1016/j.jchf.2013.07.009 PMid:24622115
    Search in Google ScholarBack to article
  11. Redfield MM, Borlaug BA. Heart failure with preserved ejection fraction. JAMA 2023;329(10):827-38. https://doi.org/10.1001/jama.2023.2020 PMid:36917048
    Search in Google ScholarBack to article
  12. Reddy YN, Kaye DM, Handoko ML, van de Bovenkamp AA, Tedford RJ, Keck C, et al. Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea. JAMA Cardiol. 2022;7(9):891-9. https://doi.org/10.1001/jamacardio.2022.1916 PMid:35830183
    Search in Google ScholarBack to article
  13. Jain CC, Borlaug BA. Performance and interpretation of invasive hemodynamic exercise testing. Chest. 2020;158(5):2119-29. https://doi.org/10.1016/j.chest.2020.05.552 PMid:32473950
    Search in Google ScholarBack to article
  14. Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong JJ, Anavekar N, et al. Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial. Circ Heart Fail. 2018;11(7):e004962. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004962 PMid:29980595
    Search in Google ScholarBack to article
  15. Costanzo MR, Stevenson LW, Adamson PB, Desai AS, Heywood JT, Bourge RC, et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. J Am Coll Cardiol Heart Fail. 2016;4(5):333-44. https://doi.org/10.1016/j.jchf.2015.11.011 PMid:26874388
    Search in Google ScholarBack to article
  16. Teramoto K, Teng TH, Chandramouli C, Tromp J, Sakata Y, Lam CS. Epidemiology and clinical features of heart failure with preserved ejection fraction. Card Fail Rev. 2022;8:e27. https://doi.org/10.15420/cfr.2022.06 PMid:35991117
    Search in Google ScholarBack to article
  17. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263-71. https://doi.org/10.1016/j.jacc.2013.02.092 PMid:23684677
    Search in Google ScholarBack to article
  18. Kawano H, Fuiwara A, Kai H, Kumagai E, Okamoto R, Shibata R, et al. Effects of blood pressure lowering in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis. Hypertens Res. 2019;42(4):504-13. https://doi.org/10.1038/s41440-019-0216-8 PMid:30948821
    Search in Google ScholarBack to article
  19. Kristensen SL, Jhund PS, Lee MM, Køber L, Solomon SD, Granger CB, et al. Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes. Cardiovasc Drugs Ther. 2017;31(5-6):545-9. https://doi.org/10.1007/s10557-017-6754-x PMid:28948430
    Search in Google ScholarBack to article
  20. Lam CS. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction. Diab Vasc Dis Res. 2015;12(4):234-8. https://doi.org/10.1177/1479164115579006 PMid:25908570
    Search in Google ScholarBack to article
  21. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451-61. https://doi.org/10.1056/NEJMoa2107038 PMid:34449189
    Search in Google ScholarBack to article
  22. Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: A randomized clinical trial. JAMA. 2016;315(1):36-46. https://doi.org/10.1001/jama.2015.17346 PMid:26746456
    Search in Google ScholarBack to article
  23. Kitzman DW, Whellan DJ, Duncan P, Pastva AM, Mentz RJ, Reeves GR, et al. Physical rehabilitation for older patients hospitalized for heart failure. N Engl J Med. 2021;385(3):203216. https://doi.org/10.1056/NEJMoa2026141
    Search in Google ScholarBack to article
  24. Lam CS, Donal E, Kraigher-Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(1):18-28. https://doi.org/10.1093/eurjhf/hfq121 PMid:20685685
    Search in Google ScholarBack to article
  25. Vaduganathan M, Piccini JP, Camm AJ, Crijns HJ, Anker SD, Butler J, et al. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: A post-hoc analysis of the ATHENA trial. Eur J Heart Fail. 2022;24(6):1094-101. https://doi.org/10.1002/ejhf.2487 PMid:35293087
    Search in Google ScholarBack to article
  26. Packer DL, Piccini JP, Monahan KH, Al-Khalidi HR, Silverstein AP, Noseworthy PA, et al. Ablation versus drug therapy for atrial fibrillation in heart failure: Results from the CABANA trial. Circulation. 2021;143(14):1377-90. https://doi.org/10.1161/CIRCULATIONAHA.120.050991 PMid:33554614
    Search in Google ScholarBack to article
  27. Vaduganathan M, Docherty DF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, et al. SGLT-2 inhibitors in patients with heart failure: A comprehensive meta-analysis of five randomised controlled trials. Lancet. 2022;400(10354):757-67. https://doi.org/10.1016/S0140-6736(22)01429-5 PMid:36041474
    Search in Google ScholarBack to article
  28. Solomon SD, McMurray JJ, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089-98. https://doi.org/10.1056/NEJMoa2206286 PMid:36027570
    Search in Google ScholarBack to article
  29. Solomon SD, McMurray JJ, Anand IS, Ge J, Lam CS, Maggioni AP, et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. 2019;381(17):1609-20. https://doi.org/10.1056/NEJMoa1908655 PMid:31475794
    Search in Google ScholarBack to article
  30. Solomon SD, Vaduganathan M, Claggett BL, Packer M, Zile M, Swedberg K, et al. Sacubitril/valsartan across the spectrum of ejection fraction in heart failure. Circulation 2020;141(5):352-61. https://doi.org/10.1161/CIRCULATIONAHA.119.044586 PMid:31736342
    Search in Google ScholarBack to article
  31. Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, et al. Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial. Circulation. 2015;131(1):34-42. https://doi.org/10.1161/CIRCULATIONAHA.114.013255 PMid:25406305
    Search in Google ScholarBack to article
  32. Solomon SD, Claggett B, Lewis EF, Desai A, Anand I, Sweitzer NK, et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J. 2016;37(5):455-62. https://doi.org/10.1093/eurheartj/ehv464 PMid:26374849
    Search in Google ScholarBack to article
DOI: https://doi.org/10.3889/seejca.2023.6051 | Journal eISSN: 1857-9361
Journal RSS Feed
Language: English
Page range: 52 - 57
Submitted on: May 31, 2023
Accepted on: Aug 4, 2023
Published on: Dec 25, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Heart failure,
HF with preserved EF,
Management HFpEF
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology,
Surgery,
Vascular surgery

© 2023 Sidhi Laksono, Robby Franata, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 4 (2023): Issue 1 (December 2023)Next article